Latest Breaking News On - உயிரி தொழில்நுட்பவியல் மாநாடு - Page 3 : comparemela.com

DiaMedica Therapeutics to Participate in the BTIG Virtual Biotechnology Conference (Nasdaq: DMAC), a clinical - stage biopharmaceutical company focused on developing novel treatments for . Autore : DiaMedica Therapeutics to Participate in the BTIG Virtual Biotechnology Conference (Di giovedì 29 luglio 2021) (Nasdaq: DMAC), a clinical - stage biopharmaceutical company focused on developing novel treatments for neurological disorders and kidney diseases, today announced that the Rick Pauls, President and . Leggi su 01net DiaMedica Therapeutics to Participate in the BTIG Virtual Biotechnology Conference Business Wire Business Wire - 29 Luglio 2021 MINNEAPOLIS - - (BUSINESS WIRE) - - DiaMedica . DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical - stage biopharmaceutical company focused on developing novel treatments for neurological disorders and kidney diseases, today announced that the .

Rick paulsDiamedica therapeuticsBiotechnology conferenceரிக் பால்ஸ்உயிரி தொழில்நுட்பவியல் மாநாடு